We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Lexaria Bioscience Corporation | NASDAQ:LEXX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.54 | -15.47% | 2.95 | 3.00 | 3.20 | 3.53 | 2.95 | 3.50 | 185,054 | 23:13:25 |
1. Name and Address of Reporting Person * DOCHERTY JOHN MARTIN | 2. Issuer Name and Ticker or Trading Symbol Lexaria Bioscience Corp. [ LEXX ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) President |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
common shares | 54075 | I | Private Holding Company |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Options | $9.6 | 4/23/2020 | 4/23/2025 | Common Shares | 13334 | 13334 | D | ||||||||
Stock Options | $5.31 | 4/26/2021 | 4/26/2026 | Common Shares | 18000 | 31334 | D | ||||||||
Stock Options | $7.08 | 6/8/2021 | 6/8/2026 | Common Shares | 18334 | 49668 | D | ||||||||
Stock Options | $6.23 | 9/1/2021 | A | 15000 | 9/1/2021 | 9/1/2026 | Common Shares | 15000 | $0 | 64668 | D |
Explanation of Responses: |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
DOCHERTY JOHN MARTIN 23 MIKELEN DRIVE PORT PERRY, A6 L9L 1V1 | X | President |
Signatures | ||
/John Docherty/ | 9/2/2021 | |
**Signature of Reporting Person | Date |
1 Year Lexaria Bioscience Chart |
1 Month Lexaria Bioscience Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions